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The usefulness of different magnet-
ic resonance (MR) imaging se-
quences (coronal and sagittal spin-
echo [SE] and three-dimensional fast
low-angle shot [3D FLASH]) in the
detection of pituitary microadeno-
mas before and after gadolinium in-
jection was prospectively evaluated
in 28 patients with surgical confir-
mation. When evaluated separately,
the most useful sequences in the de-
tection of these microadenomas
were coronal pregadolinium Ti-
weighted SE, coronal pregadolinium
3D FLASH, coronal postgadolinium
Ti-weighted SE, and coronal post-
gadolinium 3D FLASH. The combi-
nation of pre- and postgadolinium
Ti-weighted sequences with pre-
and postgadolinium 3D FLASH se-
quences produced the highest num-
ber of true-positive findings (90%)
and the lowest number of false-pos-
itive findings (5%). When a i.5-T
imaging unit with a high signal-to-
noise ratio allowing useful three-di-
mensional acquisition is used, the
authors advocate a coronal Ti-
weighted SE sequence, followed (if
necessary) by a coronal 3D FLASH
sequence, both without injection of
gadolinium, in the diagnosis of pi-
tuitary microadenomas. When no
confident diagnosis is reached, the
same sequences should be per-
formed after the injection of gado-
linium. The sagittal pre- and post-
gadolinium Ti-weighted SE and
long-TR SE sequences are useful
only in specific cases.
Index terms: Gadolinium #{149}Magnetic reso-
nance (MR), comparative studies #{149}Magnetic
resonance (MR), contrast enhancement #{149}Pitu-
itary, MR studies, 145.1214 #{149}Pituitary, neo-
plasms, 145.363
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H ICH-RESOLUTION high-magnetic-
field magnetic resonance (MR)
imaging is becoming widely accepted
as the most sensitive imaging meth-
od in the diagnosis of pituitary mi-
croadenomas. A true-positive rate of
81%-100% has been reported in MR
imaging at 1 .5 T in the detection of
microadenomas without injection of
contrast material (1-4). Previous
studies also suggest a higher mate of
detection after gadolinium injection
(5-8). The aim of this study was to
evaluate different sequences and
gadolinium injection in the diagnosis
of pituitary microadenomas by
means of optimized high-resolution,
high-magnetic-field-strength MR im-
aging with the capability of three-di-
mensional acquisition. The use of
three-dimensional acquisition is
promising in the diagnosis of pitu-
itary microadenomas. Indeed, the
very small section thickness (up to 1
mm) and high signal-to-noise ratio of
three-dimensional acquisition are im-
portant advantages with respect to
the conventional spin-echo (SE) se-
quences (minimal section thickness
of 2 mm produces a poor signal-to-
noise ratio, to improve which neces-
sitates four or eight excitations).
PATIENTS AND METHODS
Seventy-seven patients suspected of
having microadenomas on the basis of
clinical and/on computed tomographic
(CT) findings were evaluated between
September 1987 and April 1989 on a i.5-T
MR imaging unit (Magnetom; Siemens,
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that allowed three-dimensional acquisi-
tions. Twenty-eight patients underwent a
transsphenoidal exploration; this report
covers only the data from these patients.
The microadenoma was found during
surgery in 27 patients (20 patients with a
prolactinoma, six with an adnenocortico-
tropic hormone (ACTH)-secneting adeno-
ma, and one patient with a growth-hon.
mone-secreting microadenoma). In one
patient with Cushing syndrome, only a
multinodular hyperplasia was found. The
indications for surgery in the patients
with prolactinomas were the patient’s
preference for surgical removal of the mi-
croadenoma and the unsuccessful or ill-
tolerated treatment with bromocniptine.
The transsphenoidal resection was pen-
formed only if a focal abnormality and/on
indirect signs of a microadenoma were
present at CT and/or MR imaging con-
jointly with an abnormal prolactin level.
In seven cases of Cushing syndrome din-
ically suspected to be of pituitary origin,
the transsphenoidal exploration was start-
ed on the side of focal abnormality detect-
ed at CT and/or MR imaging. If no ade-
noma was found, a total hypophysectomy
was performed (one patient).
All patients were initially evaluated
without gadolinium injection. A coronal
Ti-weighted SE 600/15 (repetition time
[TR] msec/echo time [TE] msec) sequence
with four excitations was performed in all
28 patients who underwent surgery, and
a coronal three-dimensional fast low-an-
gle shot (3D FLASH) (40-70/6, one on two
excitations, 32 or 64 partitions) was per-
formed in 27 patients (one technical mci-
dent [motion of the patient] occurred). A
sagittal Ti-weighted SE 600/15 sequence
with two averages was performed in 18
patients, and a coronal bong-TR SE 2,200-
2,500/22 and 90/2 sequence was pen-
formed in six patients.
To compare the effect of gadolinium in-
jection in most patients, the postgadolin-
ium Ti-weighted sequences (coronal and
sagittal Ti-weighted SE and 3D FLASH)
Abbreviations: ACTH adrenocorticotropic
hormone, PPV = positive predictive value, SE
= spin echo, TE = echo time, 3D FLASH
three-dimensional fast low-angle shot, TR =
repetition time.
M
A
D
A
M
E
T
E
A
11
10
9
8.
7
6
5
4
3-
1_
0
A M 12
* , + A
:   I 10
 I 8
D
*, 6
4-
2
*
M 14
A 12
10
D 8
A 6
M
E ‘
T 2
E
R
M 14
A 12
10
* * -*
%
70 _
0 
8
6
4
2
D
A
M
E
T
E
A
* *-
50
40
30
20
10
0
T
P
C
a
S
e
S
% 70
% 70
060
I
T4#{176}
P30
C20
a
S
e ,,
S
60
50
40
30
20
10
0
I
T
P
C
a
S
e
S
%
65
0
I 
45
T
P
C
a
S
e
S
35-
25
15
420 #{149}Radiology August 1990
2
EiD
Figure 1. The location of the focal abnon-
mality was defined by dividing the coronal
plane of the antehypophysis into nine seg-
ments. The coronal diameter of the focal ab-
normality was measured in millimeters.
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Figure 2. Plot of the diameters of micro-
adenomas on coronal Ti-weighted SE im-
ages obtained before administration of gad-
olinium versus the diameters of these mi-
croadenomas at surgery. See text for
explanation of sensitivity*.
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Figure 3. Plot of the diameters of micro-
adenomas on coronal 3D FLASH images ob-
tamed before administration of gadolinium
versus the diameters of these microadeno-
mas at surgery. See text for explanation of
sensitivity*.
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Figure 4. Plot of the diameters of micro-
adenomas on coronal Ti-weighted SE im-
ages obtained after administration of gado-
linium versus the diameters of these micro-
adenomas at surgery. See text for explana-
tion of sensitivity*.
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Figure 5. Plot of the diameters of micro-
adenomas on coronal 3D FLASH images ob-
tamed after administration of gadolinium
versus the diameters of these microadeno-
mas at surgery. See text for explanation of
sensitivity*.
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Figure 6. Distribution of the percentage of
overlapping of true-positive (TP) findings in
the coronal cross-sectional area at surgery
and findings on coronal Ti-weighted SE im-
ages obtained before administration of gad-
olinium in 19 patients.
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Figure 7. Distribution of the percentage of
overlapping of true-positive (TP) findings in
the coronal cross-sectional area at surgery
and findings on coronal 3D FLASH images
obtained before administration of gadolini-
urn in 18 patients.
0 10 20 30 40 50 60 70 80 90 100
PERCENTAGE OF OVERLAPPING
Figure 8. Distribution of the percentage of
overlapping of true-positive (TP) findings in
the coronal cross-sectional area at surgery
and findings on coronal Ti-weighted SE im-
ages obtained after administration of gado-
linium in 13 patients.
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Figure 9. Distribution of the percentage of
overlapping of tme-positive (TP) findings in
the coronal cross-sectional area at surgery
and findings on coronal 3D FLASH images
obtained after administration of gadolinium
in 15 patients.
were performed after a period not exceed-
ing 1 week. (In all patients an injection of
1 13.07 mg/kg tetnaazacyclododecanete-
tnaacetic acid [Guerbet, Paris] was pen-
formed in 30-60 seconds, and the first se-
quence [coronal Ti-weighted SE] was
started immediately after it.) The postga-
dolinium coronal Ti-weighted SE se-
quence was performed in 24 patients and
was followed by a sagittal Ti-weighted
SE sequence in 13 patients and/or by a 3D
FLASH sequence in 22 patients. The post-
gadolinium study was not performed in
patients whose clinical, CT, and/or MR
precontrast imaging data sufficed to en-
able confident diagnosis.
For all SE sequences the section thick-
ness was 3 mm; for 3D FLASH it was 1.5
mm. For SE sequences 13-15 sections
were used; for 3D FLASH, 64 sections
were used. All MR examinations were
performed with a i.5-T (Magnetom, Sie-
mens) system with a field of view of 22
cm and a circularly polarized head coil.
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Table 1
Results in 28 Patients Who Underwent Surgery
Sequence
Coronal
Group
Coronal
Ti-weighted
SE - Gd
Coronal
Ti-weighted
SE + Gd
Coronal
3D FLASH
-Gd
Coronal
3D FLASH
+Gd
Sagittal
Ti-weighted
SE - Gd
Sagittal
Ti-weighted
SE + Gd
Proton
Density
SE
Coronal
T2-weighted
SE
All 28 patients (27 micro-
adenomas and one multinodular
hyperplasia
Nex/Nmi 28/27 25/24 27/26 23/22 18/18 13/13 6/6 6/6
No. of true-positive imaging
examinations 19 13 18 15 ii 7 3 2
Sensitivity(%)
Positive predictive value (%)
No. of false-positive imaging
examinations
70
90
2
54
87
2
69
78
5
68
83
3
61
73
4
54
64
4
50
100
0
33
100
0
Prolactinomas (20 patients, 20
microadenomas)
Nex/Nmi
No. of true-positive imaging
examinations
20/20
14
19/19
9
20/20
14
17/17
11
14/14
9
11/11
5
4/4
1
4/4
1
Sensitivity (%)
Positive predictive value (%)
No. of false-positive imaging
examinations
70
88
2
47
82
2
70
82
3
64
92
1
64
90
1
45
63
3
ND
ND
0
ND
ND
0
Cushing disease (seven patients; six
microadenomas and one multi-
nodular hypenplasia
Nex/Nmi 7/6 6/5 6/5 6/5 4/4 2/2 1/1 1/1
No. of true-positive imaging
examinations 4 4 4 4 3 2 0 1
Sensitivity (%)
Positive predictive value (%)
No. of false-positive imaging
examinations
67
100
0
80
100
0
80
67
2
80
67
2
ND
ND
1
ND
ND
0
ND
ND
0
ND
ND
0
Growth hormone secretion (one patient,
one microadenoma)
Nex/Nmi 1/1 ND 1/1 ND ND ND 1/1 1/1
No. of true-positive imaging
examinations 1 ND 0 ND ND ND 1 1
No. of false-positive imaging
examinations 0 ND 0 ND ND ND 0 0
Note-The microadenoma was found in 27 patients. In one patient with Cushing disease, only multinodular hyperplasia was found. The sensitivity
calculations apply only to a specific group of surgical patients with positive results of examination with CT and/or MR imaging. -Gd - before administration
of gadolinium, +Gd = after administration of gadolinium, ND no data, Nex/Nmi = no. of patients examined with a given sequence/no. of microadenomas
found at surgery.
The 3D FLASH studies were performed
with a 40#{176}flip angle and a 96-mm-thick
three-dimensional volume.
The location and size of the focal ab-
normality were prospectively evaluated
by two neuroradiologists in agreement
about its presence (Fig 1). Secondary
signs of mass effect were not taken into
account for this evaluation. All transs-
phenoidal explorations were performed
by a single neurosurgeon, who evaluated
the location and size of microadenomas
by using the scheme in Figure 1. With
these data, the capability of different se-
quences to enable location and measure-
ment of the diameter of microadenomas
was evaluated with three considerations
in mind:
1. Positive predictive value (PPV)
(number of patients with an adenoma and
positive test results)/(number of patients
with positive test results), and sensitivity
= (number of patients with an adenoma
and positive test results)/(numben of pa-
tients with adenoma). (Because the find-
ings at MR imaging influenced the selec-
tion of patients for surgery, the PPV was
calculated. The sensitivity calculations
apply only for a specific group of postsur-
gical patients with positive CT and/on
MR findings. In other words, patients
who had microadenomas without typical
hormonal secretion and without focal be-
sions on CT scans and/or MR images did
not undergo surgery, so that results for
the sensitivity* values were biased
[marked with * for these reasons]. If the
number of imaging examinations used to
calculate PPV and sensitivity* was equal
to on lower than four, only the number of
true-positive results and the number of
false-positive results were recorded. For
the same reasons, the negative predictive
value and the specificity* were not calcu-
bated either [only one patient had no ade-
noma at surgery]).
2. A scatter plot was made of the diam-
eters of microadenomas at surgery versus
the diameters of these microadenomas at
examination with coronal Ti-weighted
SE images obtained before the adminis-
tration of gadolinium (Fig 2), coronal 3D
FLASH images obtained before the ad-
ministration of gadolinium (Fig 3), coro-
nab Ti-weighted SE images obtained after
the administration of gadolinium (Fig 4),
and coronal 3D FLASH images obtained
after the administration of gadolinium
(Fig 5).
3. The distribution of the true-positive
MR imaging findings was determined on
the basis of the percentage of overlapping
between the surgical and MR imaging
findings (Figs 6-9).
The finding of a focal abnormality was
considered true positive only when at
least 20% of the lesion on the surgeon’s
anatomic grid overlapped the lesion on
the MR image and the side (left or right)
of the location was the same on both the
grid and the MR image. Otherwise, the
finding was considered false positive in
conjunction with false negative. The pres-
ence of a second focal abnormality distant
from the true-positive one was consid-
ered false positive in conjunction with a
true-positive finding.
Furthermore, we investigated combina-
tions of sequences to find out which pro-
vided the highest nate of true-positive
findings and the lowest rate of false-posi-
tive findings.
RESULTS
The results are summarized in Ta-
ble 1.
Combination of
Coronal Sequences
No. of True-Positive
Findings
No. of
False-Positive
Findings
Ti SE - Gd 14 (66.6) 1 (4.7)
T1SE+Gd 11(52.3) 2(9.5)
3D FLASH - Gd i5 (71.4) 3 (i4.3)
3D FLASH + Gd 15 (71.4) 2(9.5)
Ti SE - Gd
3D FLASH - Gd
16 (76.2) 1 (4.7)
T1SE-Gd
Ti SE + Gd
17(81) 1(4.7)
Ti SE - Gd
3D FLASH - Gd
Ti SE + Gd
18 (85.7) 1 (4.7)
Ti SE - Gd
3D FLASH - Gd
Ti SE + Gd
3D FLASH + Gd
19 (90.4) i (4.7)
Note-The statistics were calculated in 21 patients for whom all four sequences were performed.
Numbers in parentheses are percentages. Ti SE - Gd coronal Ti-weighted SE sequence performed
before administration of gadolinium, Ti SE + Cd corona! Ti-weighted SE image obtained after
administration of gadolinium, 3D FLASH - Gd = coronal 3D FLASH image obtained before adininis-
tration of gadolinium, 3D FLASH + Gd coronal 3D FLASH image obtained after administration of
gadolinium. Positive predictive value for the combination of all four sequences was 95%.
Table 3
Positive and Negative Yield of Gadolinium Injection in Patients
Coronal Ti-weighted SE and 3D FLASH Imaging Studies
Who Underwent
No. of
True-Positive Positive Negative
Findings in Yield in Yield in
Pregadolinium False-Negative True-Positive
Sequence Sequence Cases Cases
Corona! Ti-weighted 16 (67) 3 (38)
SE (24 patients)
Coronal 3D FLASH (21 patients) i5 (7i) 2 (33)
6(38)
5 (33)
Note-The statistics were calculated in the patients who underwent pre- and postgadolinium stud-
ies. Numbers in parentheses are percentages.
422 #{149}Radiology August i990
Patients with Adenoma
at Surgery
The best sensitivity* was achieved,
in decreasing order, with these se-
quences: pregadolinium coronal Ti-
weighted SE (70%), pregadolinium
coronal 3D FLASH (69%), postgado-
linium coronal 3D FLASH (68%), pre-
gadolinium sagittal Ti-weighted SE
(61%), postgadolinium coronal and
sagittal Ti-weighted SE (54%), coronal
bong-TR short-TE SE (50%), and coro-
nab long-TR bong-TE SE (33%). The
low signal intensity of the long-TR SE
sequence explains the absence of
false-positive examinations, low sen-
sitivity,* and high PPV. Furthermore,
this sequence was performed only in
six patients. For other sequences, the
highest PPV was achieved with cono-
nal pregadolinium Ti-weighted SE
(90%) and coronal postgadolinium Ti-
weighted SE (87%) images. The capa-
bility to evaluate the diameter of the
microadenoma with the most effec-
tive techniques (pre- or postgadolin-
ium coronal Ti-weighted SE and con-
onal 3D FLASH sequences) is repre-
sented on a scatter plot of diameters
measured at MR imaging versus di-
ameters measured at surgery (only
true-positive cases) (Figs 2-5). The
general accuracy of diameter measure-
ment for true-positive cases was very
good when pre- on postgadolinium
coronal Ti-weighted SE and 3D
FLASH images were used.
The maximum error never exceed-
ed 2 mm, except for a prolactinoma
with a diameter of 10 mm, recorded
as 14 mm when a coronal postgado-
linium Ti-weighted SE sequence was
used and as 13 mm when a coronal
postgadolinium 3D FLASH sequence
was used. The lowest dispersion of
MR imaging measurements was ob-
served with use of pregadolinium
coronal 3D FLASH images (Fig 3).
The capability to evaluate the boca-
tion of the microadenoma with the
most effective sequences (pre- or
postgadolinium coronal Ti-weighted
SE and 3D FLASH sequences) is rep-
resented on a plot of the distribution
of the percentage of patients with
true-positive findings versus the per-
centage of overlap between findings
at MR imaging and findings at sum-
gery (Figs 6-9). The best results are
achieved with coronal pregadolin-
ium 3D FLASH images (61% of true-
positive cases had 100% overlapping
between the findings at MR imaging
and the findings at surgery [Fig 7])
and coronal pregadolinium Ti-
weighted SE images (41% of true-pos-
itive cases had 100% overlapping be-
tween findings at MR imaging and
Table 2
Effect of Sequence Combination on Findings
the findings at surgery [Fig 6]). The
relationship between the surgical di-
ametem of the microadenoma and the
sensitivity* of the study was also
evaluated for the pregadolinium cor-
onal Ti-weighted SE images and 3D
FLASH images. The sensitivity * im-
proved with the increasing size of
the microadenoma (100% sensitivity
in microadenomas with diameters of
9 mm or greater imaged with both se-
quences), but the sensitivity* to small
adenomas (3 mm in diameter) was
higher in 3D FLASH images (50%)
than in Ti-weighted SE images
(30%). When we considered combina-
tions of different sequences per-
formed in 21 patients for whom all
four sequences were performed (Ta-
ble 2), the best results in the detec-
tion of microadenomas were
achieved with the combination of
pre- and postgadolinium coronal Ti-
weighted SE images with pre- and
postgadolinium coronal 3D FLASH
images (PPV = 95%, number of true-
positive findings = 19 [90%], number
of false-positive findings 1 [5%]).
The combination of pre- and post-
gadolinium coronal Ti-weighted SE
images with pregadolinium coronal
3D FLASH images produced true-
positive results in 85.7% of MR imag-
ing examinations; the combination of
pre- and postgadolinium coronal Ti-
weighted SE images produced true-
positive results in 81% of MR imag-
ing examinations (Table 2). Theme
was no improvement in the detection
of microadenomas by addition of sag-
ittal pre- and postgadolinium Ti-
weighted SE images and bong-TR SE
images to the most efficient combina-
tion of the sequences (pre- and post-
gadolinium coronal Ti-weighted SE
and 3D FLASH).
a. b. C.
f.
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Patient without Adenoma at
Surgery
In one patient with cyclic Cushing
disease, only nodular hypemplasia
without evidence of microadenomas
was found. The coronal pme- and
postgadolinium SE images as well as
CT scans were normal in this patient.
The pre- and postgadolinium 3D
FLASH images showed a focal hy-
pointensity but did not enable confi-
dent diagnosis. So, in this patient,
the SE images and CT scans resulted
in a true-negative evaluation and the
3D FLASH sequence in a false-posi-
tive one. Nevertheless, after a subto-
tal hypophysectomy, the patient’s
levels of ACTH have been normal for
longer than 1 year; whether this is of
hypothalamic or pituitary origin is
still dubious.
Effects of Gadolinium Injection
Statistical analysis of the effects of
contrast material injection was per-
formed in the patients who under-
went pre- and postgadolinium stud-
ies (SE images were obtained in 24
patients and 3D FLASH images were
obtained in 21 patients). After injec-
tion of gadolinium, the microadeno-
ma could be detected in three of
eight patients who had false-negative
Ti-weighted SE images (resulting in
a positive yield of 37.5%) (positive
yield of gadolinium in the microade-
nomas negative on the pregadolin-
ium images = [number of positive
cases on postgadolinium images but
negative on pregadolinium images] /
[number of cases negative on pre-
gadolinium images]) and in two of
six patients with false-negative 3D
FLASH images (positive yield of
33.3%) (Table 3). Of 16 true-positive
findings on pregadolinium coronal
Ti-weighted SE images, six became
false negative after injection of gado-
linium (negative yield of 37.5%)
(negative yield of gadolinium in the
microadenomas positive on the pre-
gadolinium scans [number of neg-
ative cases on postgadolinium scans
but positive on pregadolinium
scans] / [number of positive cases on
pregadolinium scans]), and of 15
true-positive findings on pregado-
linum coronal 3D FLASH images,
five became false negative after injec-
tion of gadolinium (Table 3).
DISCUSSION
Recent studies of MR imaging in
the diagnosis of pituitary micmoade-
nomas still vary in their evaluation
of diagnostic accuracy and the most
useful sequence parameters of this
modality. Our study, performed at
1 .5 T, demonstrates the utility of
three-dimensional acquisition (Figs
10-12) and coronal Ti-weighted SE
images without gadolinium in the di-
agnosis of microadenomas. The high-
est sensitivity was achieved with con-
onal pregadolinium Ti-weighted SE
images (70%) and coronal pregado-
linium 3D FLASH images (69%). Re-
cent studies done with a 1 .5-T mag-
net and 3-mm thick sections (Table 4)
also suggest a high accuracy of Ti-
weighted sequences. Kucharczyk et
al (3) imaged 10 of ii ACTH-secret-
ing microadenomas (91%), Kulkamni
et al (4) imaged eight of eight micro-
adenomas (100%), Peck et al (1) im-
Figure 10. ACTH-secreting microadenoma
4 mm in diameter. (a) False-negative coronal
Ti-weighted SE, (b) false-negative sagittal
Ti-weighted SE, and (c, d) coronal 3D
FLASH images without administration of
gadolinium. (e) Coronal Ti-weighted SE and
(0 coronal 3D FLASH images obtained after
administration of gadolinium. On pregado-
binium studies (a-d), a low-contrast area of
focal hypointensity (arrow, c and d) can
only be suspected, especially with a 3D
FLASH sequence (c, d) (the pregadolinium
studies were insufficient to enable a confi-
dent diagnosis). After injection of gadolini-
um, the microadenoma (arrow, e and f) is as
cleanly visualized on the Ti-weighted SE
image (e) as on the 3D FLASH image (f).
Nevertheless, the contrast between the hy-
pophysis and microadenoma is greater on
the 3D FLASH image (6.6 for the SE image
and 8.6 for the 3D FLASH image). (The con-
trast was calculated with the following
equation: Contrast = [signal intensity of hy-
pophysis - signal intensity of microadeno-
ma] /noise.)
aged 17 of 21 ACTH-secreting mi-
croadenomas (81%), and Nichols et al
(2) imaged nine of 1 1 (six ACTH- and
five prolactin-secreting) microadeno-
mas (82%). Nevertheless, there are
also reports of a lower accuracy of
unenhanced i.5-T images. Pojunas et
al (9) failed to detect five of 1 1 pro-
lactinomas (45%), and Doppman et al
(6) failed to detect five of eight
ACTH-secreting microadenomas
(62%). The poor results of some stud-
ies can, at least in pant, be explained
by technical parameters (ie, an insuf-
ficient number of excitations [one on
two] and a small [128-pixel] matrix)
(Table 4).
The good results of 3D FLASH im-
ages can be explained by the use of
smaller sections in 3D FLASH images
and by good optimization of this se-
quence for pituitary examinations.
(After the influence of TR, flip angle,
and number of partitions versus total
acquisition volume and number of
excitations have been evaluated, the
best results in imaging the hypophy-
sis with 3D FLASH are achieved with
the following parameters: 70/6, one
excitation, 64 sections of 1 .5 mm
thickness, and zoom of 1.2. The tech-
nical factors of MR imaging equip-
ment are also important in achieving
a good contrast-to-noise ratio in
three-dimensional imaging of the
hypophysis (including a circularly
polarized head coil with a high sig-
nab-to-noise ratio, strong gradients
allowing the use of short TE, and
high homogeneity of the magnetic
field).
Nevertheless, in suboptimal condi-
tions (motion artifacts induced by
poor cooperation from the patient,
for example, on a highly pneuma-
C. d. h.
a. b. e. f.
424 #{149}Radiology August 1990
8-
Figure ii. Prolactinoma 3-4 mm in diameter that was treated with bromocriptine. (a, b) Two contiguous sections of coronal Ti-weighted
SE sequence and (c, d) two contiguous sections of sagittal Ti-weighted SE sequence, at the level of the microadenoma. (e) Coronal 3D FLASH
image obtained without administration of gadolinium. (f) Coronal Ti-weighted SE, (g) sagittal Ti-weighted SE, and (h) coronal 3D FLASH
images obtained after administration of gadolinium (f-h were obtained at the level of the microadenoma). This small microadenoma (arrow,
e), treated with bromocriptine, could be visualized only with 3D FLASH without administration of gadolinium. All other pre- or postcon-
trast sequences, as well as CT, were unable to demonstrate it.
Table 4
Parameters for Ti-weighted MR Imaging of Microadenomas at 1.5 T
True- No. of
No. of Section Positive Patients who
TR TE Signals Gap Thickness Rate Underwent
Study Sequence (msec) (msec) Averaged Matrix (mm) (mm) (%) Surgery
Kucharczyketal(3)
Kuikarni et al (4)
SE
SE
IRt
600
2000-3000
2500
25
20, 30-70, 80
20
6
2
2
256
i28
i28
0
0.6
0.6
3
3
3
91
100
11
8
Pecketal(1) SE 600 20 4 256 0.3 3 81 21
Pojunasetal(9)
Doppntanetal(6)
Nicholsetal(2)
SE
SE
SE
300-800
600
500
i4-25
20
20
lor2
2
4
128or256
256
256
0
0
0.6
3
3
3
54
38
8i
ii
8
ii
Note-ZR - inversion recovery.
* Performed with electrocardiographic gating.
t Inversion time - 800 msec.
tized sphenoid sinus that induces
susceptibility artifacts), the homoge-
neity of the three-dimensional study
can be significantly lower than that
of a conventional SE study, hence the
higher number of false-positive ex-
aminations and the lower number of
confident diagnoses with respect to
conventional SE studies.
The few reports about the diagnos-
tic utility of gadolinium studies at 1.5
T suggest a higher accuracy of post-
contrast studies (5-8). In a series of
eight ACTH-secreting microadeno-
mas imaged at 1.5 T, Doppman et al
(6) achieved accuracy rates of 38% for
true-positive precontrast studies and
50% for true-positive postcontnast
studies. Nevertheless, only two aver-
ages and a rather long TE of 20 msec
were used in this study. Davis et al
(5) found postgadolinium studies su-
penior in two of three microadeno-
mas but used only a 0.5 T MR imag-
ing unit and a 5-mm section thick-
ness. The study of Dwyem et al (7) (in
which 13 ACTH-secreting micro-
adenomas were imaged) reported
that eight of 12 surgically confirmed
microadenomas were seen on pmegad-
olinium studies and none were seen
on postgadolinium studies. Dwyer et
al also used a 0.5-T MR imaging unit
and a 5-mm section thickness. In our
experience, when evaluated separate-
by, the pmegadolinium studies en-
abled greater diagnostic accuracy
than the postgadolinium studies.
This can be explained by technical
factors discussed in Patients and
Methods. These factors allow the vi-
sualization of micmoadenomas which,
when lower-resolution equipment is
used, can be visualized only after ad-
ministration of gadolinium (Fig 13).
Another factor can be a flip-flop from
dark to bright after injection of gado-
linium, with a frequent period of
isointensity between the hypophysis
and microadenoma during which the
presence of gadolinium may obscure
rather than help to visualize the le-
sion (7) (Figs 14, i5). In our expeni-
ence the negative yield after injec-
C. d.
i. j.
a. b. e. f.
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Figure 12. Probactinoma 3 mm in diameter. (a-c) Three contiguous
sections of postgadolinium coronal Ti-weighted SE sequence. (d) An-
tenor section (at the bevel of the microadenoma) of coronal Ti-
weighted SE sequence obtained without administration of gadolini-
urn. (e) Left parasagittai section (at the level of the microadenoma) of
sagittal Ti-weighted SE sequence obtained without administration of
gadolinium. (f-h) Three contiguous sections (at the level of the mi-
croadenoma) of postgadolinium sagittal Ti-weighted SE sequence.
(i-l) Four contiguous sections of postgadolmnium 3D FLASH se-
quence obtained from behind to front. This microadenoma was clear-
by visualized with postgadolmnium 3D FLASH only (arrow, 1). On an-
tenor sections of pregadolinium (d) and postgadolinium coronal Ti-
weighted SE (C) sequences, the diagnosis is dubious. A large
hypointense area (arrows, a and b) on posterior sections is explain-
abbe with sagittal Ti-weighted SE images (c-h) as a partial volume ef-
fed of the hypophysis and the clivus (arrow, g and h), but the micro-
adenoma itself is not visualized.
k. L
tion of gadolinium was 37.5% for con-
onal Ti-weighted SE images and
33.3% for coronal 3D FLASH images.
The positive yield after injection of
gadolinium was 37.5% for coronal Ti-
weighted SE images and 33.3% for
coronal 3D FLASH images.
Our results agree with the pmevi-
ously reported limited value of sagit-
tal Ti-weighted SE images (especially
because of the high rate of false-posi-
tive findings) and long-TR SE images
(1,4,6,9). In our study, the sensitiv-
ity* of long-TR SE images was low
(Fig 13), and the combination with
other sequences never improved the
total sensitivity. Nevertheless, these
sequences were performed only in
six patients who underwent surgery.
We agree with Peck et al (1) that
the sagittal Ti-weighted SE image is
also of limited value because of par-
tial volume artifacts caused by the ca-
motid artery and difficulties in com-
paring the left and right parts of the
hypophysis.
The combination of sagittal pre-
and postgadolinium studies with con-
onal pre- and postgadolinium Ti-
weighted SE studies and coronal pme-
and postgadolinium 3D FLASH stud-
ies has not improved the sensitivity
or the PPV. Almost all authors recog-
nize the superiority of Ti-weighted
coronal SE images. We found no re-
ports about the value of the combina-
tion of different sequences. In our ex-
perience, the most useful combina-
tion of sequences is the pre- and
postgadolinium coronal Ti-weighted
SE image with the pre- and postgado-
linium 3D FLASH image. This corn-
bination produced the highest nurn-
ben of true-positive cases (90.4%) and
the lowest number of false-positive
cases (4.7%). The two false-negative
cases (incidentally also false negative
at CT) were the prolactinomas treated
with Parbodel (bmomocniptine mesy
late; Sandoz, Parsippany, NJ) (Fig 16).
Therefore, the pmecontrast Se-
quences that were evaluated sepa-
rately gave a higher accuracy than
the postcontrast ones, but the cornbi-
nation of both allows the highest ac-
curacy. The CT scans in our study
d. e. h.
1
1.
k.
a. b. C.
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were heterogeneous, most of them
having been obtained in other hospi-
tals; they were not included in our
evaluation.
CONCLUSION
For a i.5-T MR imaging unit with a
high signal-to-noise ratio that allows
useful three-dimensional acquisi-
tions, we advocate the following
scheme of sequences for the diagno-
sis of pituitary microadenomas: a con-
onal Ti-weighted SE sequence fob-
lowed by a coronal 3D FLASH se-
quence (if the coronal Ti-weighted
SE sequence does not allow the diag-
nosis), both without injection of gad-
olinium. When confident diagnosis
still is not reached, the same se-
quences should be performed after
the injection of gadolinium. The sag-
ittal Ti-weighted SE sequence (with
or without injection of gadolinium)
and bong-TR SE sequence are useful
only in specific cases. The high-field-
strength MR imaging unit with a
1. m.
Figure 13 ACTH-secreting microadenoma 4 mm in diameter. (a) Coronal pnegadoliniuin
Ti-weighted SE image. (b) Sagittal postgadolinium Ti-weighted SE image. (c) Coronal post-
gadolinium Ti-weighted SE image. These images (a-c) were obtained with a i.5-T magnet, a
3-mm section thickness, four averages, TR of 450 msec, and TE of 30 msec. The hyperintense
focal lesion (arrow, b and c) is poorly demonstrated on postgadolinium sequences only.
(d, e) Coronal pregadolinium Ti-weighted SE images obtained at levels 5.4 (d) and 8.4 (e).
(f, g) Coronal pregadolinium 3D FLASH images obtained at levels 6.9 (f) and 8.4 (g).
(h, i) Coronal proton-density SE images obtained by means of a 2.3/22 sequence with two
averages at levels 5.4 (h) and 8.4 (i). (j, k) Coronal T2-weighted SE images obtained by means
of a 2,300/90 sequence with two averages at levels 5.4 (j) and 8.4 (k). (1) Coronal postgadolin-
ium Ti-weighted SE image. (m) Coronal postgadolmnium 3D FLASH image. These images
(d-m), obtained at our institution 2 months after a-c were obtained, clearly demonstrate a
microadenoma on pregadolmnium Ti-weighted SE images (d, e) and 3D FLASH images
(f, g) as an area of focal hypointensity. (Note higher contrast between hypophysis and ade-
noma on 3D FLASH images.) On the postgadolinium Ti-weighted SE image (1) and 3D
FLASH image (m) the microadenoma was hyperintense (arrow, 1 and m). The long-TR se-
quences (h-k) have a limited value. Indeed, only the anterior, probably more cystic, part of
the microadenoma (arrow) can be visualized on the T2-weighted SE image (k).
high signal-to-noise ratio and three-
dimensional capabilities enables sen-
sitive imaging for pmesurgical evalua-
tion of pituitary microadenomas. U
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